About this trial
In this study, Chinese residents aged 35 to 75 years old were recruited from Fujian Province. Physical examination, questionnaire survey and biological sample collection were performed at baseline, and at least 4 years of follow-up were conducted. Information on newly discovered cardiovascular metabolic illnesses and comorbidities was collected during follow-up, and repeated surveys similar to baseline were conducted. To explore the relationship between environment, diet and lifestyle and the risk of cardiovascular metabolic diseases and concomitant disorders.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Aged 35-75, having lived in Fuzhou, Putian, Quanzhou, Nanping, Xiamen, Zhangzhou, Longyan, Sanming, or Ningde in Fujian Province for more than 6 months.
Disqualifiers
Anyone diagnosed with coronary heart disease, stroke, or cancer.
Anyone with a severe disability who is unable to participate in the study.
Trial population
A total of 150,000 adult China aged 35 to 74 who have lived in urban or rural areas of Fuzhou, Putian, Quanzhou, Nanping, Xiamen, Zhangzhou, Longyan, Sanming and Ningde in Fujian Province for more than 6 months without cardiovascular disease history and major disability.
Trial design
Cohort
Prospective
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
Coronary Disease
It is a form of myocardial ischemia (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels. At the follow-up, the outcomes of coronary events were acquired. Coronary CTA examination and coronary angiography were the primary measuring modalities.
Secondary outcomes
other metabolic diseases
Including hypertension, stroke, diabetes, impaired glucose tolerance, obesity, cancer, chronic obstructive pulmonary disease and chronic kidney disease. These disorders were diagnosed using international standards, and the necessary information was gathered during face-to-face follow-up.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Fujian Provincial Hospital
Lead sponsor
Center for Disease Control and Prevention, Fujian
Collaborator
China National Center for Cardiovascular Diseases
Collaborator